Skip to content
value.today

Eximis Surgical Inc.

🇺🇸 Louisville, Colorado, USAHealth CareFounded 2014
Total raised
$39 M
4 rounds on record
Latest round
$15 M
Mar 2023
First round on record
Dec 2017
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Eximis Surgical Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2023$15 MNo. 4$10 to $50 million

Eximis Surgical Inc.: Raise no. 4, Mar 2023

Investors in this round

12 investors had bought by the notice of May 10, 2024: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $16 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Donna Ford-Serbu · Executive Officer, Director
  • Brian Butler · Director
  • Ryan Drant · Director
  • Scott Button · Director
  • Scott Hutton · Director
  • Theodore Lamson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Donna Ford-Serbu, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed May 10, 2024. Read the notice at the SEC.

equitySEC
Oct 2018$17 MNo. 3$10 to $50 million

Eximis Surgical Inc.: Raise no. 3, Oct 2018

Investors in this round

2 investors had bought by the notice of Feb 28, 2020: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $19 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kristin Johnson · Executive Officer, Director, Promoter
  • Michael Kramer · Executive Officer
  • Donna Ford-Serbu · Director, Promoter
  • Michael Blomeyer · Director
  • Ryan Drant · Director
  • Scott Button · Director
  • Scott Hutton · Director
  • Theodore Lamson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kristin Johnson, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Feb 28, 2020. Read the notice at the SEC.

equitySEC
Feb 2018$5 MNo. 2$2 to $10 million

Eximis Surgical Inc.: Raise no. 2, Feb 2018

Investors in this round

29 investors had bought by the notice of Mar 2, 2018: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kristin Johnson · Executive Officer, Director, Promoter
  • Donna Ford-Serbu · Director, Promoter
  • Michael Blomeyer · Director
  • Scott Hutton · Director
  • Theodore Lamson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The total amount sold includes shares issued upon conversion of outstanding notes and the conversion of Series X Preferred Stock valued at $1,249,998 as previously reported to the SEC in a Form D filed on December 11, 2017.”

Signed by Kristin Johnson, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 2, 2018. Read the notice at the SEC.

equitySEC
Dec 2017$1 MNo. 1Under $2 million

Eximis Surgical Inc.: Raise no. 1, Dec 2017

Investors in this round

5 investors had bought by the notice of Dec 11, 2017: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kristin Johnson · Executive Officer, Director, Promoter
  • Donna Ford-Serbu · Director, Promoter
  • Michael Blomeyer · Director
  • William Gregg · Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kristin Johnson, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 11, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Eximis Surgical Inc. chose not to state its revenue in its newest notice of a funding round (May 2024).

    SEC Form D · May 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · May 2024

That is all the official record says: Eximis Surgical Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Eximis Surgical Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 29 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Eximis Surgical Inc.
NameRoleNamed in
Donna Ford-SerbuExecutive officerMay 2024
Kristin JohnsonExecutive officerApr 2023
Michael KramerExecutive officerFeb 2020
Brian ButlerDirectorMay 2024
Donna Ford-SerbuDirectorMay 2024
Ryan DrantDirectorMay 2024
Scott ButtonDirectorMay 2024
Scott HuttonDirectorMay 2024
Theodore LamsonDirectorMay 2024
Kristin JohnsonDirectorFeb 2020
Michael BlomeyerDirectorFeb 2020
William GreggDirectorDec 2017
Donna Ford-SerbuPromoterFeb 2020
Kristin JohnsonPromoterFeb 2020
William GreggPromoterDec 2017